Guggenheim Capital LLC Medicinova Inc Transaction History
Guggenheim Capital LLC
- $13.9 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding MNOV
# of Institutions
34Shares Held
4.69MCall Options Held
7.2KPut Options Held
3.8K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.01 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.13 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA459KShares$834,9520.0% of portfolio
-
Citigroup Inc448KShares$815,2810.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $89.3M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...